Ovarian hyperstimulation syndrome

Changed by Henry Knipe, 27 Sep 2022
Disclosures - updated 6 Apr 2022:
  • Radiopaedia Events Pty Ltd, Speaker fees (past)
  • Integral Diagnostics, Shareholder (ongoing)
  • Micro-X Ltd, Shareholder (ongoing)

Updates to Article Attributes

Body was changed:

Ovarian hyperstimulation syndrome (OHSS) is a complication of controlled ovarian stimulation treatment (ovarian induction therapy), which is an assisted reproduction technique used for in vitro fertilisation (IVF). Rarely, it may also occur spontaneously in pregnancy (see below). It consists of ovarian enlargement with the extravascular accumulation of fluid leading to variable weight gain, ascitespleural effusionseffusion, intravascular volume depletion, and oliguria.

Epidemiology

The syndrome is relatively common, occurring in ~5% of patients undergoing in vitro fertilisation (IVF). There is probably an even higher incidence of the syndrome in "egg donors" due to their young age (which is a known risk factor for the disease) however there is a known problem of lack of reporting of such cases.

Risk factors
  • high baseline ovarian volume 8
  • background polycystic ovaries 9
  • low body weight 8
  • long ovulation induction cycle duration 8

Clinical presentation

The clinical picture may vary from abdominal distension and discomfort to potentially life-threatening capillary leak with fluid sequestration in a third space, and massive ovarian enlargement.  PainPain, abdominal distention, nausea, and vomiting are frequently seen as symptoms18.

Pathology

ItControlled ovarian stimulation is an assisted reproductive technique used to increase oocyte (egg) retrieval success and can cause ovarian hyperstimulation syndrome 18.

This syndrome is characterised by massive cystic ovarian enlargement and fluid shift from the intravascular compartment into the peritoneal, pleural or pericardial spaces. The vascular fluid leakage is thought to result from an increased capillary permeability of mesothelial surfaces under the action of one or several vasoactive ovarian factors produced by multiple corpora lutea. Acute pelvic pain may result from stretching of the ovarian capsule or haemorrhage/rupture of a follicle.

Markers
  • serum oestradiol (E2) levels are elevated18
Subtypes
Spontaneous ovarian hyperstimulation

This subtype occurs in the absence of any external stimulation. This form can occur in pregnancy 15.

There are also very rare sporadic forms whichthat carry a genetic component. These have an association with early pubertal development and primary hypothyroidism (Van Wyk-Grumbach syndrome). Ovarian stimulation in the hypothyroid child may result in oestrogen production, breast development, endometrial proliferation, and vaginal bleeding. It is likely that raised TSH concentrations bind and stimulate the FSH receptor, although a similar overlap phenomenon might occur at the level of the pituitary, with enhanced TRH production stimulating the GnRH receptor with subsequent ovarian enlargement. The cystic ovarian enlargement resolves with thyroid hormone replacement. A hyperstimulation phenomenon in patients with an abnormal FSH receptor has been described.

Classification

Based on the clinical presentation and imaging findings, the modified Golan classification subdivides OHSS 12,17.

Radiographic features

Imaging findings tend to be similar on ultrasound, CT and MRI.

Ultrasound

Treatment and prognosis

The syndrome is usually self-limiting in most cases and management is mainly supportive, however, cases with fatal outcomeoutcomes have been reported 14. Severe cases usually require hospitalizationhospitalisation and close monitoring of haematocrit, liver function, renal function, serum electrolytes and oxygen saturation.

The profoundly altered maternal environment of OHSS is a significant risk factor for miscarriage, especially when occurring in the early phase after IVF (defined as <10 days after oocyte retrieval) 16.

Complications

Differential diagnosis

For ultrasound appearances in mild cases consider

Practical points

Familiarity with ovarian hyperstimulation syndrome and the appropriate clinical setting should help avoid the incorrect diagnosis of an ovarian cystic neoplasm. OnWhen encountering severe forms not suspected by the clinician suggesting the diagnosis may reduce both morbidity and mortality.

  • -<p><strong>Ovarian hyperstimulation syndrome (OHSS)</strong> is a complication of ovarian stimulation treatment (ovarian induction therapy) for <a href="/articles/in-vitro-fertilisation-ivf">in vitro fertilisation</a>. Rarely, it may also occur spontaneously in pregnancy (see below). It consists of ovarian enlargement with extravascular accumulation of fluid leading to variable weight gain, <a href="/articles/ascites">ascites</a>, <a href="/articles/pleural-effusion">pleural effusions</a>​, intravascular volume depletion and oliguria.</p><h4>Epidemiology</h4><p>The <a href="/articles/syndrome">syndrome</a> is relatively common, occurring in ~5% of patients undergoing in vitro fertilisation (IVF). There is probably an even higher incidence of the syndrome in "egg donors" due to their young age (which is a known risk factor for the disease) however there is a known problem of lack of reporting of such cases.</p><h5>Risk factors</h5><ul>
  • +<p><strong>Ovarian hyperstimulation syndrome (OHSS)</strong> is a complication of controlled ovarian stimulation, which is an assisted reproduction technique used for in vitro fertilisation (IVF). Rarely, it may also occur spontaneously in pregnancy (see below). It consists of ovarian enlargement with the extravascular accumulation of fluid leading to variable weight gain, <a href="/articles/ascites">ascites</a>, <a href="/articles/pleural-effusion">pleural effusion</a>, intravascular volume depletion, and oliguria.</p><h4>Epidemiology</h4><p>The <a href="/articles/syndrome">syndrome</a> is relatively common, occurring in ~5% of patients undergoing in vitro fertilisation (IVF). There is probably an even higher incidence of the syndrome in "egg donors" due to their young age (which is a known risk factor for the disease) however there is a known problem of lack of reporting of such cases.</p><h5>Risk factors</h5><ul>
  • -</ul><h4>Clinical presentation</h4><p>The clinical picture may vary from abdominal distension and discomfort to potentially life-threatening capillary leak with fluid sequestration in a third space, and massive ovarian enlargement.  Pain, abdominal distention, nausea, and vomiting are frequently seen as symptoms.</p><h4>Pathology</h4><p>It is characterised by massive cystic ovarian enlargement and fluid shift from the intravascular compartment into the peritoneal, pleural or pericardial spaces. The vascular fluid leakage is thought to result from an increased capillary permeability of mesothelial surfaces under the action of one or several vasoactive ovarian factors produced by multiple <a href="/articles/corpus-luteum">corpora lutea</a>. Acute pelvic pain may result from stretching of the ovarian capsule or haemorrhage/rupture of a <a href="/articles/ovarian-follicle">follicle</a>.</p><h5>Markers</h5><ul><li>serum oestradiol (E<sub>2</sub>) levels are elevated</li></ul><h5>Subtypes</h5><h6>Spontaneous ovarian hyperstimulation</h6><p>This subtype occurs in the absence of any external stimulation. This form can occur in pregnancy <sup>15</sup>.</p><p>There are also very rare sporadic forms which carry a genetic component. These have an association with early pubertal development and primary hypothyroidism (<a href="/articles/van-wyk-grumbach-syndrome">Van Wyk-Grumbach syndrome</a>). Ovarian stimulation in the <a href="/articles/hypothyroidism">hypothyroid</a> child may result in oestrogen production, breast development, endometrial proliferation, and vaginal bleeding. It is likely that raised TSH concentrations bind and stimulate the FSH receptor, although a similar overlap phenomenon might occur at the level of the pituitary, with enhanced TRH production stimulating the GnRH receptor with subsequent ovarian enlargement. The cystic ovarian enlargement resolves with thyroid hormone replacement. A hyperstimulation phenomenon in patients with an abnormal FSH receptor has been described.</p><h4>Classification</h4><p>Based on the clinical presentation and imaging findings, the <a href="/articles/modified-golan-classification-of-ovarian-hyperstimulation-syndrome">modified Golan classification</a> subdivides OHSS <sup>12,17</sup>.</p><h4>Radiographic features</h4><p>Imaging findings tend to be similar on ultrasound, CT and MRI.</p><h5>Ultrasound</h5><ul>
  • +</ul><h4>Clinical presentation</h4><p>The clinical picture may vary from abdominal distension and discomfort to potentially life-threatening capillary leak with fluid sequestration in a third space, and massive ovarian enlargement. Pain, abdominal distention, nausea, and vomiting are frequently seen as symptoms <sup>18</sup>.</p><h4>Pathology</h4><p>Controlled ovarian stimulation is an assisted reproductive technique used to increase oocyte (egg) retrieval success and can cause ovarian hyperstimulation syndrome <sup>18</sup>.</p><p>This syndrome is characterised by massive cystic ovarian enlargement and fluid shift from the intravascular compartment into the peritoneal, pleural or pericardial spaces. The vascular fluid leakage is thought to result from an increased capillary permeability of mesothelial surfaces under the action of one or several vasoactive ovarian factors produced by multiple <a href="/articles/corpus-luteum">corpora lutea</a>. Acute pelvic pain may result from stretching of the ovarian capsule or haemorrhage/rupture of a <a href="/articles/ovarian-follicle">follicle</a>.</p><h5>Markers</h5><ul><li>serum oestradiol (E<sub>2</sub>) levels are elevated <sup>18</sup>
  • +</li></ul><h5>Subtypes</h5><h6>Spontaneous ovarian hyperstimulation</h6><p>This subtype occurs in the absence of any external stimulation. This form can occur in pregnancy <sup>15</sup>.</p><p>There are also very rare sporadic forms that carry a genetic component. These have an association with early pubertal development and primary hypothyroidism (<a href="/articles/van-wyk-grumbach-syndrome">Van Wyk-Grumbach syndrome</a>). Ovarian stimulation in the <a href="/articles/hypothyroidism">hypothyroid</a> child may result in oestrogen production, breast development, endometrial proliferation, and vaginal bleeding. It is likely that raised TSH concentrations bind and stimulate the FSH receptor, although a similar overlap phenomenon might occur at the level of the pituitary, with enhanced TRH production stimulating the GnRH receptor with subsequent ovarian enlargement. The cystic ovarian enlargement resolves with thyroid hormone replacement. A hyperstimulation phenomenon in patients with an abnormal FSH receptor has been described.</p><h4>Classification</h4><p>Based on the clinical presentation and imaging findings, the <a href="/articles/modified-golan-classification-of-ovarian-hyperstimulation-syndrome">modified Golan classification</a> subdivides OHSS <sup>12,17</sup>.</p><h4>Radiographic features</h4><p>Imaging findings tend to be similar on ultrasound, CT and MRI.</p><h5>Ultrasound</h5><ul>
  • -</ul><h4>Treatment and prognosis</h4><p>The syndrome is usually <a href="/articles/self-limiting-2">self-limiting</a> in most cases and management is mainly supportive, however, cases with fatal outcome have been reported <sup>14</sup>. Severe cases usually require hospitalization and close monitoring of haematocrit, liver function, renal function, serum electrolytes and oxygen saturation.</p><p>The profoundly altered maternal environment of OHSS is a significant risk factor for <a href="/articles/miscarriage">miscarriage</a>, especially when occurring in the early phase after IVF (defined as &lt;10 days after oocyte retrieval) <sup>16</sup>.</p><h5>Complications</h5><ul>
  • +</ul><h4>Treatment and prognosis</h4><p>The syndrome is usually <a href="/articles/self-limiting-2">self-limiting</a> in most cases and management is mainly supportive, however, cases with fatal outcomes have been reported <sup>14</sup>. Severe cases usually require hospitalisation and close monitoring of haematocrit, liver function, renal function, serum electrolytes and oxygen saturation.</p><p>The profoundly altered maternal environment of OHSS is a significant risk factor for <a href="/articles/miscarriage">miscarriage</a>, especially when occurring in the early phase after IVF (defined as &lt;10 days after oocyte retrieval) <sup>16</sup>.</p><h5>Complications</h5><ul>
  • -</ul><h4>Practical points</h4><p>Familiarity with ovarian hyperstimulation syndrome and the appropriate clinical setting should help avoid the incorrect diagnosis of an <a href="/articles/ovarian-cystic-neoplasms-1">ovarian cystic neoplasm</a>. On encountering severe forms not suspected by the clinician suggesting the diagnosis may reduce both morbidity and mortality.</p>
  • +</ul><h4>Practical points</h4><p>Familiarity with ovarian hyperstimulation syndrome and the appropriate clinical setting should help avoid the incorrect diagnosis of an <a href="/articles/ovarian-cystic-neoplasms-1">ovarian cystic neoplasm</a>. When encountering severe forms not suspected by the clinician suggesting the diagnosis may reduce both morbidity and mortality.</p>

References changed:

  • 1. Smits G, Olatunbosun O, Delbaere A, Pierson R, Vassart G, Costagliola S. Ovarian Hyperstimulation Syndrome Due to a Mutation in the Follicle-Stimulating Hormone Receptor. N Engl J Med. 2003;349(8):760-6. <a href="https://doi.org/10.1056/NEJMoa030064">doi:10.1056/NEJMoa030064</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/12930928">Pubmed</a>
  • 2. Sultan A, Velaga M, Fleet M, Cheetham T. Cullen's Sign and Massive Ovarian Enlargement Secondary to Primary Hypothyroidism in a Patient with a Normal FSH Receptor. Arch Dis Child. 2006;91(6):509-10. <a href="https://doi.org/10.1136/adc.2005.088443">doi:10.1136/adc.2005.088443</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/16714722">Pubmed</a>
  • 3. Jung B & Kim H. Severe Spontaneous Ovarian Hyperstimulation Syndrome with MR Findings. J Comput Assist Tomogr. 2001;25(2):215-7. <a href="https://doi.org/10.1097/00004728-200103000-00009">doi:10.1097/00004728-200103000-00009</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/11242215">Pubmed</a>
  • 4. Bennett G, Slywotzky C, Giovanniello G. Gynecologic Causes of Acute Pelvic Pain: Spectrum of CT Findings. Radiographics. 2002;22(4):785-801. <a href="https://doi.org/10.1148/radiographics.22.4.g02jl18785">doi:10.1148/radiographics.22.4.g02jl18785</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/12110710">Pubmed</a>
  • 5. Jung S, Byun J, Lee J et al. MR Imaging of Maternal Diseases in Pregnancy. AJR Am J Roentgenol. 2001;177(6):1293-300. <a href="https://doi.org/10.2214/ajr.177.6.1771293">doi:10.2214/ajr.177.6.1771293</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/11717069">Pubmed</a>
  • 6. Pedrosa I, Zeikus E, Levine D, Rofsky N. MR Imaging of Acute Right Lower Quadrant Pain in Pregnant and Nonpregnant Patients. Radiographics. 2007;27(3):721-43; discussion 743-53. <a href="https://doi.org/10.1148/rg.273065116">doi:10.1148/rg.273065116</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/17495289">Pubmed</a>
  • 7. Delbaere A, Smits G, De Leener A, Costagliola S, Vassart G. Understanding Ovarian Hyperstimulation Syndrome. Endocrine. 2005;26(3):285-90. <a href="https://doi.org/10.1385/ENDO:26:3:285">doi:10.1385/ENDO:26:3:285</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/16034183">Pubmed</a>
  • 8. Danninger B, Brunner M, Obruca A, Feichtinger W. Prediction of Ovarian Hyperstimulation Syndrome by Ultrasound Volumetric Assessment [corrected] of Baseline Ovarian Volume Prior to Stimulation. Hum Reprod. 1996;11(8):1597-9. <a href="https://doi.org/10.1093/oxfordjournals.humrep.a019451">doi:10.1093/oxfordjournals.humrep.a019451</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/8921098">Pubmed</a>
  • 9. Rizk B & Smitz J. Ovarian Hyperstimulation Syndrome After Superovulation Using GnRH Agonists for IVF and Related Procedures. Hum Reprod. 1992;7(3):320-7. <a href="https://doi.org/10.1093/oxfordjournals.humrep.a137642">doi:10.1093/oxfordjournals.humrep.a137642</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/1587936">Pubmed</a>
  • 10. Papanikolaou E, Pozzobon C, Kolibianakis E et al. Incidence and Prediction of Ovarian Hyperstimulation Syndrome in Women Undergoing Gonadotropin-Releasing Hormone Antagonist in Vitro Fertilization Cycles. Fertil Steril. 2006;85(1):112-20. <a href="https://doi.org/10.1016/j.fertnstert.2005.07.1292">doi:10.1016/j.fertnstert.2005.07.1292</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/16412740">Pubmed</a>
  • 11. Kim I & Lee B. Ovarian Hyperstimulation Syndrome. US and CT Appearances. Clin Imaging. 1997;21(4):284-6. <a href="https://doi.org/10.1016/s0899-7071(96)00044-7">doi:10.1016/s0899-7071(96)00044-7</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/9215477">Pubmed</a>
  • 12. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian Hyperstimulation Syndrome: An Update Review. Obstet Gynecol Surv. 1989;44(6):430-40. <a href="https://doi.org/10.1097/00006254-198906000-00004">doi:10.1097/00006254-198906000-00004</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/2660037">Pubmed</a>
  • 13. Kasum M. New Insights in Mechanisms for Development of Ovarian Hyperstimulation Syndrome. Coll Antropol. 2010;34(3):1139-43. - <a href="https://www.ncbi.nlm.nih.gov/pubmed/20977119">Pubmed</a>
  • 14. Semba S, Moriya T, Youssef E, Sasano H. An Autopsy Case of Ovarian Hyperstimulation Syndrome with Massive Pulmonary Edema and Pleural Effusion. Pathol Int. 2000;50(7):549-52. <a href="https://doi.org/10.1046/j.1440-1827.2000.01082.x">doi:10.1046/j.1440-1827.2000.01082.x</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/10886738">Pubmed</a>
  • 15. Lovgren T, Tomich P, Smith C, Berg T, Maclin V. Spontaneous Severe Ovarian Hyperstimulation Syndrome in Successive Pregnancies with Successful Outcomes. Obstet Gynecol. 2009;113(2 Pt 2):493-5. <a href="https://doi.org/10.1097/AOG.0b013e318184182b">doi:10.1097/AOG.0b013e318184182b</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/19155932">Pubmed</a>
  • 16. Papanikolaou E, Tournaye H, Verpoest W et al. Early and Late Ovarian Hyperstimulation Syndrome: Early Pregnancy Outcome and Profile. Hum Reprod. 2005;20(3):636-41. <a href="https://doi.org/10.1093/humrep/deh638">doi:10.1093/humrep/deh638</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/15576388">Pubmed</a>
  • 17. Golan A & Weissman A. A Modern Classification of OHSS. Reprod Biomed Online. 2009;19(1):28-32. <a href="https://doi.org/10.1016/s1472-6483(10)60042-9">doi:10.1016/s1472-6483(10)60042-9</a>
  • 18. Nastri C, Teixeira D, Moroni R, Leitão V, Martins W. Ovarian Hyperstimulation Syndrome: Pathophysiology, Staging, Prediction and Prevention. Ultrasound Obstet Gynecol. 2015;45(4):377-93. <a href="https://doi.org/10.1002/uog.14684">doi:10.1002/uog.14684</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/25302750">Pubmed</a>
  • 1. Smits G, Olatunbosun O, Delbaere A et-al. Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N. Engl. J. Med. 2003;349 (8): 760-6. <a href="http://dx.doi.org/10.1056/NEJMoa030064">doi:10.1056/NEJMoa030064</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/12930928">Pubmed citation</a><div class="ref_v2"></div>
  • 2. Sultan A, Velaga MR, Fleet M et-al. Cullen's sign and massive ovarian enlargement secondary to primary hypothyroidism in a patient with a normal FSH receptor. Arch. Dis. Child. 2006;91 (6): 509-10. <a href="http://dx.doi.org/10.1136/adc.2005.088443">doi:10.1136/adc.2005.088443</a> - <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2082807">Free text at pubmed</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/16714722">Pubmed citation</a><div class="ref_v2"></div>
  • 3. Jung BG, Kim H. Severe spontaneous ovarian hyperstimulation syndrome with MR findings. J Comput Assist Tomogr. 25 (2): 215-7. <a href="http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0363-8715&volume=25&issue=2&spage=215">J Comput Assist Tomogr (link)</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/11242215">Pubmed citation</a><div class="ref_v2"></div>
  • 4. Bennett GL, Slywotzky CM, Giovanniello G. Gynecologic causes of acute pelvic pain: spectrum of CT findings. Radiographics. 22 (4): 785-801. <a href="http://radiographics.rsna.org/content/22/4/785.full">Radiographics (full text)</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/12110710">Pubmed citation</a><div class="ref_v2"></div>
  • 5. Jung SE, Byun JY, Lee JM et-al. MR imaging of maternal diseases in pregnancy. AJR Am J Roentgenol. 2001;177 (6): 1293-300. <a href="http://www.ajronline.org/cgi/content/full/177/6/1293">AJR Am J Roentgenol (full text)</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/11717069">Pubmed citation</a><div class="ref_v2"></div>
  • 6. Pedrosa I, Zeikus EA, Levine D et-al. MR imaging of acute right lower quadrant pain in pregnant and nonpregnant patients. Radiographics. 27 (3): 721-43. <a href="http://dx.doi.org/10.1148/rg.273065116">doi:10.1148/rg.273065116</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/17495289">Pubmed citation</a><div class="ref_v2"></div>
  • 7. Delbaere A, Smits G, De leener A et-al. Understanding ovarian hyperstimulation syndrome. Endocrine. 2005;26 (3): 285-90. <a href="http://dx.doi.org/10.1385/ENDO:26:3:285">doi:10.1385/ENDO:26:3:285</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/16034183">Pubmed citation</a><div class="ref_v2"></div>
  • 8. Danninger B, Brunner M, Obruca A et-al. Prediction of ovarian hyperstimulation syndrome by ultrasound volumetric assessment [corrected] of baseline ovarian volume prior to stimulation. Hum. Reprod. 1996;11 (8): 1597-9. <a href="http://humrep.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=8921098">Hum. Reprod. (link)</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/8921098">Pubmed citation</a><div class="ref_v2"></div>
  • 9. Rizk B, Smitz J. Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures. Hum. Reprod. 1992;7 (3): 320-7. <a href="http://humrep.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=1587936">Hum. Reprod. (link)</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/1587936">Pubmed citation</a><div class="ref_v2"></div>
  • 10. Papanikolaou EG, Pozzobon C, Kolibianakis EM et-al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil. Steril. 2006;85 (1): 112-20. <a href="http://dx.doi.org/10.1016/j.fertnstert.2005.07.1292">doi:10.1016/j.fertnstert.2005.07.1292</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/16412740">Pubmed citation</a><div class="ref_v2"></div>
  • 11. Kim IY, Lee BH. Ovarian hyperstimulation syndrome. US and CT appearances. Clin Imaging. 21 (4): 284-6. <a href="http://linkinghub.elsevier.com/retrieve/pii/S0899707196000447">Clin Imaging (link)</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/9215477">Pubmed citation</a><div class="ref_v2"></div>
  • 12. Golan A, Ron-el R, Herman A et-al. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 1989;44 (6): 430-40. <a href="http://www.ncbi.nlm.nih.gov/pubmed/2660037">Pubmed citation</a><span class="auto"></span>
  • 13. Kasum M. New insights in mechanisms for development of ovarian hyperstimulation syndrome. Coll Antropol. 2010;34 (3): 1139-43. <a href="http://www.ncbi.nlm.nih.gov/pubmed/20977119">Pubmed citation</a><span class="auto"></span>
  • 14. Semba S, Moriya T, Youssef EM et-al. An autopsy case of ovarian hyperstimulation syndrome with massive pulmonary edema and pleural effusion. Pathol. Int. 2000;50 (7): 549-52. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10886738">Pubmed citation</a><span class="auto"></span>
  • 15. Lovgren TR, Tomich PG, Smith CV et-al. Spontaneous severe ovarian hyperstimulation syndrome in successive pregnancies with successful outcomes. Obstet Gynecol. 2009;113 (2, Part 2): 493-5. <a href="http://dx.doi.org/10.1097/AOG.0b013e318184182b">doi:10.1097/AOG.0b013e318184182b</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/19155932">Pubmed citation</a><span class="auto"></span>
  • 16. Papanikolaou EG, Tournaye H, Verpoest W et-al. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum. Reprod. 2005;20 (3): 636-41. <a href="http://dx.doi.org/10.1093/humrep/deh638">doi:10.1093/humrep/deh638</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/15576388">Pubmed citation</a><span class="auto"></span>
  • 17. Golan A, Weissman A. A modern classification of OHSS. Reproductive BioMedicine Online. 2009;19(1):28-32.

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.